(Q33998693)

30 July 2017

1 reference

title

Influence of lipoproteins on microglial degradation of Alzheimer's amyloid beta-protein (English)

1 reference

30 July 2017

0 references

0 references

1 reference

Cole GM

1 reference

30 July 2017

Ard MD

series ordinal

1 reference

30 July 2017

publication date

1 August 2000

1 reference

Microscopy Research and Technique

30 July 2017

published in

1 reference

30 July 2017

1 reference

30 July 2017

1 reference

30 July 2017

page(s)

316-324

1 reference

Identification of scavenger receptor SR-BI as a high density lipoprotein receptor

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820000815%2950%3A4%3C316%3A%3AAID-JEMT11%3E3.0.CO%3B2-E

Interaction of nascent ApoE2, ApoE3, and ApoE4 isoforms expressed in mammalian cells with amyloid peptide beta (1-40). Relevance to Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820000815%2950%3A4%3C316%3A%3AAID-JEMT11%3E3.0.CO%3B2-E

Scavenging of Alzheimer's amyloid beta-protein by microglia in culture.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820000815%2950%3A4%3C316%3A%3AAID-JEMT11%3E3.0.CO%3B2-E

Lack of apolipoprotein E dramatically reduces amyloid beta-peptide deposition

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820000815%2950%3A4%3C316%3A%3AAID-JEMT11%3E3.0.CO%3B2-E

Cholesterol modulates alpha-secretase cleavage of amyloid precursor protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820000815%2950%3A4%3C316%3A%3AAID-JEMT11%3E3.0.CO%3B2-E

Apolipoprotein E carboxyl-terminal fragments are complexed to amyloids A and L. Implications for amyloidogenesis and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820000815%2950%3A4%3C316%3A%3AAID-JEMT11%3E3.0.CO%3B2-E

Fibrillogenesis in Alzheimer's disease of amyloid beta peptides and apolipoprotein E.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820000815%2950%3A4%3C316%3A%3AAID-JEMT11%3E3.0.CO%3B2-E

Native complex formation between apolipoprotein E isoforms and the Alzheimer's disease peptide A beta.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820000815%2950%3A4%3C316%3A%3AAID-JEMT11%3E3.0.CO%3B2-E

Effect of chloroquine and leupeptin on intracellular accumulation of amyloid-beta (A beta) 1-42 peptide in a murine N9 microglial cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820000815%2950%3A4%3C316%3A%3AAID-JEMT11%3E3.0.CO%3B2-E

Uptake, degradation, and release of fibrillar and soluble forms of Alzheimer's amyloid beta-peptide by microglial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820000815%2950%3A4%3C316%3A%3AAID-JEMT11%3E3.0.CO%3B2-E

Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820000815%2950%3A4%3C316%3A%3AAID-JEMT11%3E3.0.CO%3B2-E

Abnormal content of n-6 and n-3 long-chain unsaturated fatty acids in the phosphoglycerides and cholesterol esters of parahippocampal cortex from Alzheimer's disease patients and its relationship to acetyl CoA content

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820000815%2950%3A4%3C316%3A%3AAID-JEMT11%3E3.0.CO%3B2-E

Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820000815%2950%3A4%3C316%3A%3AAID-JEMT11%3E3.0.CO%3B2-E

Scavenger receptor-mediated adhesion of microglia to beta-amyloid fibrils

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820000815%2950%3A4%3C316%3A%3AAID-JEMT11%3E3.0.CO%3B2-E

Appearance of sodium dodecyl sulfate-stable amyloid beta-protein (Abeta) dimer in the cortex during aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820000815%2950%3A4%3C316%3A%3AAID-JEMT11%3E3.0.CO%3B2-E

Apolipoprotein E is a kinetic but not a thermodynamic inhibitor of amyloid formation: implications for the pathogenesis and treatment of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820000815%2950%3A4%3C316%3A%3AAID-JEMT11%3E3.0.CO%3B2-E

High density lipoprotein decreases beta-amyloid toxicity in cortical cell culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820000815%2950%3A4%3C316%3A%3AAID-JEMT11%3E3.0.CO%3B2-E

Ultrastructure of the microglia that phagocytose amyloid and the microglia that produce beta-amyloid fibrils

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820000815%2950%3A4%3C316%3A%3AAID-JEMT11%3E3.0.CO%3B2-E

Abeta-peptide length and apolipoprotein E genotype in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820000815%2950%3A4%3C316%3A%3AAID-JEMT11%3E3.0.CO%3B2-E

The cerebrospinal-fluid soluble form of Alzheimer's amyloid beta is complexed to SP-40,40 (apolipoprotein J), an inhibitor of the complement membrane-attack complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820000815%2950%3A4%3C316%3A%3AAID-JEMT11%3E3.0.CO%3B2-E

Abnormal in vivo metabolism of apolipoprotein E4 in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820000815%2950%3A4%3C316%3A%3AAID-JEMT11%3E3.0.CO%3B2-E

Interaction of apolipoprotein J-amyloid beta-peptide complex with low density lipoprotein receptor-related protein-2/megalin. A mechanism to prevent pathological accumulation of amyloid beta-peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820000815%2950%3A4%3C316%3A%3AAID-JEMT11%3E3.0.CO%3B2-E

Confirmation of an association between a polymorphism in exon 3 of the low-density lipoprotein receptor-related protein gene and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820000815%2950%3A4%3C316%3A%3AAID-JEMT11%3E3.0.CO%3B2-E

Expression of human apolipoprotein E reduces amyloid-beta deposition in a mouse model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820000815%2950%3A4%3C316%3A%3AAID-JEMT11%3E3.0.CO%3B2-E

Immunohistochemical evidence for a macrophage scavenger receptor in Mato cells and reactive microglia of ischemia and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820000815%2950%3A4%3C316%3A%3AAID-JEMT11%3E3.0.CO%3B2-E

Abeta1-40 but not Abeta1-42 levels in cortex correlate with apolipoprotein E epsilon4 allele dosage in sporadic Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820000815%2950%3A4%3C316%3A%3AAID-JEMT11%3E3.0.CO%3B2-E

Microglia and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820000815%2950%3A4%3C316%3A%3AAID-JEMT11%3E3.0.CO%3B2-E

Alzheimer's soluble amyloid beta protein is secreted by HepG2 cells as an apolipoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820000815%2950%3A4%3C316%3A%3AAID-JEMT11%3E3.0.CO%3B2-E

Multiple inhibitory effects of Alzheimer's peptide Abeta1-40 on lipid biosynthesis in cultured human HepG2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820000815%2950%3A4%3C316%3A%3AAID-JEMT11%3E3.0.CO%3B2-E

Sequestration of acetylated LDL and cholesterol crystals by human monocyte-derived macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820000815%2950%3A4%3C316%3A%3AAID-JEMT11%3E3.0.CO%3B2-E

Water-soluble Abeta (N-40, N-42) oligomers in normal and Alzheimer disease brains

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820000815%2950%3A4%3C316%3A%3AAID-JEMT11%3E3.0.CO%3B2-E

Activation of phospholipase A2 by amyloid beta-peptides in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820000815%2950%3A4%3C316%3A%3AAID-JEMT11%3E3.0.CO%3B2-E

Amyloid beta peptide alters intracellular vesicle trafficking and cholesterol homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820000815%2950%3A4%3C316%3A%3AAID-JEMT11%3E3.0.CO%3B2-E

Cell surface proteoglycans modulate net synthesis and secretion of macrophage apolipoprotein E.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820000815%2950%3A4%3C316%3A%3AAID-JEMT11%3E3.0.CO%3B2-E

Apolipoprotein E. Structure, function, and possible roles in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820000815%2950%3A4%3C316%3A%3AAID-JEMT11%3E3.0.CO%3B2-E

Preferential deposition of amyloid beta protein (Abeta) in the form Abeta40 in Alzheimer's disease is associated with a gene dosage effect of the apolipoprotein E E4 allele.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820000815%2950%3A4%3C316%3A%3AAID-JEMT11%3E3.0.CO%3B2-E

Apolipoprotein J and Alzheimer's amyloid beta solubility

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820000815%2950%3A4%3C316%3A%3AAID-JEMT11%3E3.0.CO%3B2-E

Amyloid beta-peptide induces apoptosis-related events in synapses and dendrites

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820000815%2950%3A4%3C316%3A%3AAID-JEMT11%3E3.0.CO%3B2-E

Deposition of amyloid beta protein (A beta) subtypes [A beta 40 and A beta 42(43)] in canine senile plaques and cerebral amyloid angiopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820000815%2950%3A4%3C316%3A%3AAID-JEMT11%3E3.0.CO%3B2-E

Apolipoprotein B immunoreactivity in senile plaque and vascular amyloids and neurofibrillary tangles in the brains of patients with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820000815%2950%3A4%3C316%3A%3AAID-JEMT11%3E3.0.CO%3B2-E

Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820000815%2950%3A4%3C316%3A%3AAID-JEMT11%3E3.0.CO%3B2-E

Apolipoprotein E ε4 allele is associated with deposition of amyloid β-protein following head injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820000815%2950%3A4%3C316%3A%3AAID-JEMT11%3E3.0.CO%3B2-E

Distribution of apolipoprotein E in senile plaques in brains with Alzheimer's disease: investigation with the confocal laser scan microscope

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820000815%2950%3A4%3C316%3A%3AAID-JEMT11%3E3.0.CO%3B2-E

Microglial cells internalize aggregates of the Alzheimer's disease amyloid beta-protein via a scavenger receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820000815%2950%3A4%3C316%3A%3AAID-JEMT11%3E3.0.CO%3B2-E

Slow degradation of aggregates of the Alzheimer's disease amyloid beta-protein by microglial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820000815%2950%3A4%3C316%3A%3AAID-JEMT11%3E3.0.CO%3B2-E

Detection of apolipoprotein E/dimeric soluble amyloid beta complexes in Alzheimer's disease brain supernatants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820000815%2950%3A4%3C316%3A%3AAID-JEMT11%3E3.0.CO%3B2-E

Multiple, diverse senile plaque-associated proteins are ligands of an apolipoprotein E receptor, the alpha 2-macroglobulin receptor/low-density-lipoprotein receptor-related protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820000815%2950%3A4%3C316%3A%3AAID-JEMT11%3E3.0.CO%3B2-E

Opposite roles of apolipoprotein E in normal brains and in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820000815%2950%3A4%3C316%3A%3AAID-JEMT11%3E3.0.CO%3B2-E

Apolipoprotein E associates with beta amyloid peptide of Alzheimer's disease to form novel monofibrils. Isoform apoE4 associates more efficiently than apoE3

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820000815%2950%3A4%3C316%3A%3AAID-JEMT11%3E3.0.CO%3B2-E

Apolipoprotein E epsilon 4 allele distributions in late-onset Alzheimer's disease and in other amyloid-forming diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820000815%2950%3A4%3C316%3A%3AAID-JEMT11%3E3.0.CO%3B2-E

Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820000815%2950%3A4%3C316%3A%3AAID-JEMT11%3E3.0.CO%3B2-E

Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820000815%2950%3A4%3C316%3A%3AAID-JEMT11%3E3.0.CO%3B2-E

Transthyretin sequesters amyloid beta protein and prevents amyloid formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820000815%2950%3A4%3C316%3A%3AAID-JEMT11%3E3.0.CO%3B2-E

Amyloid beta protein (A beta) removal by neuroglial cells in culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820000815%2950%3A4%3C316%3A%3AAID-JEMT11%3E3.0.CO%3B2-E

Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820000815%2950%3A4%3C316%3A%3AAID-JEMT11%3E3.0.CO%3B2-E

Monoclonal antibodies inhibit in vitro fibrillar aggregation of the Alzheimer beta-amyloid peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820000815%2950%3A4%3C316%3A%3AAID-JEMT11%3E3.0.CO%3B2-E

Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820000815%2950%3A4%3C316%3A%3AAID-JEMT11%3E3.0.CO%3B2-E

Molecular, cellular, and pathologic characterization of HLA-DR immunoreactivity in normal elderly and Alzheimer's disease brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820000815%2950%3A4%3C316%3A%3AAID-JEMT11%3E3.0.CO%3B2-E

Soluble amyloid beta-protein is a marker of Alzheimer amyloid in brain but not in cerebrospinal fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820000815%2950%3A4%3C316%3A%3AAID-JEMT11%3E3.0.CO%3B2-E

Reactive microglia express class I and class II major histocompatibility complex antigens in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820000815%2950%3A4%3C316%3A%3AAID-JEMT11%3E3.0.CO%3B2-E

The levels of soluble versus insoluble brain Abeta distinguish Alzheimer's disease from normal and pathologic aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820000815%2950%3A4%3C316%3A%3AAID-JEMT11%3E3.0.CO%3B2-E

Seeding of A beta fibril formation is inhibited by all three isotypes of apolipoprotein E.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820000815%2950%3A4%3C316%3A%3AAID-JEMT11%3E3.0.CO%3B2-E

RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820000815%2950%3A4%3C316%3A%3AAID-JEMT11%3E3.0.CO%3B2-E

Loss of endosomal/lysosomal membrane impermeability is an early event in amyloid Abeta1-42 pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820000815%2950%3A4%3C316%3A%3AAID-JEMT11%3E3.0.CO%3B2-E

Characterization of the binding of amyloid-beta peptide to cell culture-derived native apolipoprotein E2, E3, and E4 isoforms and to isoforms from human plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820000815%2950%3A4%3C316%3A%3AAID-JEMT11%3E3.0.CO%3B2-E

Brain uptake of circulating apolipoproteins J and E complexed to Alzheimer's amyloid beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820000815%2950%3A4%3C316%3A%3AAID-JEMT11%3E3.0.CO%3B2-E

Solvation Effects on the Conformational Behaviour of Gellan and Calcium Ion Binding to Gellan Double Helices

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820000815%2950%3A4%3C316%3A%3AAID-JEMT11%3E3.0.CO%3B2-E

Amyloid-associated proteins α1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer β-protein into filaments

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820000815%2950%3A4%3C316%3A%3AAID-JEMT11%3E3.0.CO%3B2-E

Upregulation of the macrophage scavenger receptor in response to different forms of injury in the CNS

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820000815%2950%3A4%3C316%3A%3AAID-JEMT11%3E3.0.CO%3B2-E

Amyloid beta-peptide is transported on lipoproteins and albumin in human plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820000815%2950%3A4%3C316%3A%3AAID-JEMT11%3E3.0.CO%3B2-E

Characterization of subpopulations of lipoprotein particles isolated from human cerebrospinal fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820000815%2950%3A4%3C316%3A%3AAID-JEMT11%3E3.0.CO%3B2-E

Amyloid beta binding proteins in vitro and in normal human cerebrospinal fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820000815%2950%3A4%3C316%3A%3AAID-JEMT11%3E3.0.CO%3B2-E

Role of HDL apolipoprotein E in cellular cholesterol efflux: studies in apo E knockout transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820000815%2950%3A4%3C316%3A%3AAID-JEMT11%3E3.0.CO%3B2-E

The lack of accumulation of senile plaques or amyloid burden in Alzheimer's disease suggests a dynamic balance between amyloid deposition and resolution.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820000815%2950%3A4%3C316%3A%3AAID-JEMT11%3E3.0.CO%3B2-E

The soluble form of Alzheimer's amyloid beta protein is complexed to high density lipoprotein 3 and very high density lipoprotein in normal human plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820000815%2950%3A4%3C316%3A%3AAID-JEMT11%3E3.0.CO%3B2-E

Biochemical characterization of Alzheimer's soluble amyloid beta protein in human cerebrospinal fluid: association with high density lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820000815%2950%3A4%3C316%3A%3AAID-JEMT11%3E3.0.CO%3B2-E

Purification of apolipoprotein E attenuates isoform-specific binding to beta-amyloid

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820000815%2950%3A4%3C316%3A%3AAID-JEMT11%3E3.0.CO%3B2-E

Structure and functions of human cerebrospinal fluid lipoproteins from individuals of different APOE genotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820000815%2950%3A4%3C316%3A%3AAID-JEMT11%3E3.0.CO%3B2-E

Apolipoprotein E: binding to soluble Alzheimer's beta-amyloid

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820000815%2950%3A4%3C316%3A%3AAID-JEMT11%3E3.0.CO%3B2-E

Scavenger receptor family proteins: roles for atherosclerosis, host defence and disorders of the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820000815%2950%3A4%3C316%3A%3AAID-JEMT11%3E3.0.CO%3B2-E

10.1002/1097-0029(20000815)50:4<316::AID-JEMT11>3.0.CO;2-E

21 January 2018

Identifiers

DOI

1 reference

30 July 2017

1 reference